about
Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cellsThe epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin developmentNuclear signalling by tumour-associated antigen EpCAMClaudin 1 in Breast Cancer: New InsightsCirculating tumor cells isolation: the "post-EpCAM era"Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachImmunotargeting of cancer stem cellsCirculating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer researchCancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectivesDual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysisCirculating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionMechanisms involved in breast cancer liver metastasisCharacterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancerEpCAM in carcinogenesis: the good, the bad or the uglyActivator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo.Targeted methylation of the epithelial cell adhesion molecule (EpCAM) promoter to silence its expression in ovarian cancer cellsCD44s and CD44v6 expression in head and neck epithelia.Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesisNormal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistanceCirculating tumor cell identification by functionalized silver-gold nanorods with multicolor, super-enhanced SERS and photothermal resonances.Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.Pluripotency genes overexpressed in primate embryonic stem cells are localized on homologues of human chromosomes 16, 17, 19, and XClinical Pharmacology and Translational Aspects of Bispecific AntibodiesRNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule.Effects of EpCAM overexpression on human breast cancer cell linesEpothilone B enhances surface EpCAM expression in ovarian cancer Hey cellsThe novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines.A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients.High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibodyHeterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells.Epithelium percentage estimation facilitates epithelial quantitative protein measurement in tissue specimens.Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.CancerMA: a web-based tool for automatic meta-analysis of public cancer microarray data.Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110.Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastasesAptamer-based cell imaging reagents capable of fluorescence switching.High EpCAM expression is linked to proliferation and lauren classification in gastric cancer.
P2860
Q21136080-DB033C5D-69D8-41E4-99CC-C1EC894B08F8Q21563339-DD19E75B-D8A4-4FAF-84A9-3A1F0D8B8C92Q24315870-4B203198-4F0E-465D-B7BA-4FE519FD3667Q26774988-EAAC0F8A-81A1-4829-A147-2F73E9AF5637Q26778917-55CF0017-D74C-4EDF-B067-9304ED55B667Q26849477-8C029C8E-E597-4ADF-883D-61C58AFEBB30Q27014031-0DB432E5-835E-4918-BB87-2019B518A019Q27024191-DE7358E5-A652-4E52-B915-59B8BE1E8CBDQ27024651-84EF4C12-50CA-44CD-96ED-7ECDB36D79C2Q27027682-CCF9678B-EB86-4699-9BA3-C4367451703CQ28066285-6428E54F-F030-42B0-9C4D-62BECD0A2E16Q28084024-A85A4A32-C68C-407E-AAFB-E58165B5108DQ28235980-0E376B30-DF2A-4D59-9FAE-8A71DBCA5204Q28293163-BD096BC4-1462-4AD2-8187-C3CA9BD2082EQ30427356-E08948C2-D3FB-4BE2-A938-65727341CCF0Q30439008-C27424D9-0603-4F61-879D-BDCCF5895C13Q30513354-9F7FBB96-CD98-4A53-AD89-1C02B22582DEQ31149698-F33ABCD2-B552-4824-8383-46E10D9B091FQ33375699-7609D40F-1F12-4A2B-A5EB-97C9CA78CC8DQ33539986-3ACF015F-7CC4-4B4B-92DF-AFE020012E81Q33567293-32125EF3-64B6-4F14-A68F-6A2AC24634D6Q33586566-63DDD840-0001-4B1D-9B2A-19AE27D0F57AQ33588273-E44835DB-50FA-4036-935E-9D077A47D1A6Q33636608-1581D682-0AB1-4072-8661-C028EFE16D74Q33648086-0869F05F-8F1F-4549-8225-29CB4BBC7E2DQ33807710-9ACFE058-8D22-4669-89CF-0B41DAEA0FF2Q33807783-3ED516E2-FE23-4931-A860-6C5EB2DC0B93Q34188631-485BCC06-07EB-4661-97AB-51654FB8FE97Q34223880-CBA503A6-245D-4182-92CA-979EE5196E7CQ34241985-1053535B-4B09-4606-99CC-BED0620A29C5Q34308781-BA8B2BC1-DCD6-486E-ABAF-F94A697FD9D4Q34361383-0D347AD9-BF4E-4093-B324-30701B872998Q34404833-F12D1F6E-4AE1-4E96-A269-4C1880A52DD7Q34455382-347037C0-71AF-4B0D-BBED-BF52AC17BB6FQ34461481-83287191-8AA8-485B-932C-929ED03EF90EQ34513043-8D921910-26FF-4FD1-A57C-BED03CA7098EQ34570056-6F322A4C-8B72-460A-A883-6D702037CF5BQ34589622-80A7BDDE-4078-4085-AABF-E1F386FCD83DQ34778789-D6985F05-468B-49F4-8895-1DD7E83A87E4Q34800662-1F83884F-8DA0-4710-904A-6766EA633282
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
EpCAM (CD326) finding its role in cancer
@ast
EpCAM (CD326) finding its role in cancer
@en
EpCAM (CD326) finding its role in cancer
@nl
type
label
EpCAM (CD326) finding its role in cancer
@ast
EpCAM (CD326) finding its role in cancer
@en
EpCAM (CD326) finding its role in cancer
@nl
prefLabel
EpCAM (CD326) finding its role in cancer
@ast
EpCAM (CD326) finding its role in cancer
@en
EpCAM (CD326) finding its role in cancer
@nl
P2860
P3181
P356
P1476
EpCAM (CD326) finding its role in cancer
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6603494
P407
P577
2007-02-12T00:00:00Z
P5875
P6179
1016958339